INZY
Price
$3.99
Change
-$0.01 (-0.25%)
Updated
Jun 27 closing price
Capitalization
257.6M
44 days until earnings call
PRME
Price
$2.42
Change
-$0.23 (-8.68%)
Updated
Jun 27 closing price
Capitalization
317.73M
38 days until earnings call
Interact to see
Advertisement

INZY vs PRME

Header iconINZY vs PRME Comparison
Open Charts INZY vs PRMEBanner chart's image
Inozyme Pharma
Price$3.99
Change-$0.01 (-0.25%)
Volume$4.96M
Capitalization257.6M
Prime Medicine
Price$2.42
Change-$0.23 (-8.68%)
Volume$5.5M
Capitalization317.73M
INZY vs PRME Comparison Chart in %
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. PRME commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (INZY: $3.99 vs. PRME: $2.42)
Brand notoriety: INZY and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 178% vs. PRME: 218%
Market capitalization -- INZY: $257.6M vs. PRME: $317.73M
INZY [@Biotechnology] is valued at $257.6M. PRME’s [@Biotechnology] market capitalization is $317.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 3 TA indicator(s) are bullish while PRME’s TA Score has 6 bullish TA indicator(s).

  • INZY’s TA Score: 3 bullish, 2 bearish.
  • PRME’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а 0.00% price change this week, while PRME (@Biotechnology) price change was +16.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

PRME is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($318M) has a higher market cap than INZY($258M). INZY YTD gains are higher at: 44.043 vs. PRME (-17.123). INZY has higher annual earnings (EBITDA): -100.34M vs. PRME (-200M). PRME has more cash in the bank: 144M vs. INZY (84.8M). INZY has less debt than PRME: INZY (47M) vs PRME (121M). PRME has higher revenues than INZY: PRME (3.85M) vs INZY (0).
INZYPRMEINZY / PRME
Capitalization258M318M81%
EBITDA-100.34M-200M50%
Gain YTD44.043-17.123-257%
P/E RatioN/AN/A-
Revenue03.85M-
Total Cash84.8M144M59%
Total Debt47M121M39%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYPRME
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 17 days ago
87%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTRE0.30N/A
N/A
Learning Tree International, Inc.
MPFRF3.60N/A
N/A
Mapfre SA
TOPCF22.38N/A
N/A
Topcon Corp.
RCRRF56.39-2.65
-4.49%
Recruit Holdings Co., Ltd.
GSVRF0.17-0.01
-5.68%
GUANAJUATO SILVER CO LTD

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with ACAD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-0.25%
ACAD - INZY
50%
Loosely correlated
-0.41%
KROS - INZY
43%
Loosely correlated
-0.15%
PRME - INZY
40%
Loosely correlated
-8.68%
AURA - INZY
38%
Loosely correlated
-0.16%
NGNE - INZY
38%
Loosely correlated
-2.47%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-8.68%
CRSP - PRME
61%
Loosely correlated
N/A
RXRX - PRME
56%
Loosely correlated
-6.85%
BEAM - PRME
55%
Loosely correlated
-1.98%
CRBU - PRME
52%
Loosely correlated
-5.19%
ALLO - PRME
49%
Loosely correlated
-1.67%
More